lithium has been researched along with etoposide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bais, EM; Beijnen, JH; ten Bokkel Huinink, WW | 1 |
| Beurel, E; Blivet-Van Eggelpoël, MJ; Cadoret, A; Capeau, J; Desbois-Mouthon, C; Kornprobst, M; Ruiz-Ruiz, C | 1 |
| Chen, CL; Chiang, CW; Jan, MS; Lin, CF; Lin, YS | 1 |
3 other study(ies) available for lithium and etoposide
| Article | Year |
|---|---|
Lithium pharmacokinetics during cisplatin-based chemotherapy: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bipolar Disorder; Bleomycin; Cisplatin; Drug Interactions; Etoposide; Humans; Lithium; Male; Testicular Neoplasms | 1994 |
GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression.
Topics: Apoptosis; Camptothecin; Etoposide; fas Receptor; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium; Promoter Regions, Genetic; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53 | 2004 |
Lithium inhibits ceramide- and etoposide-induced protein phosphatase 2A methylation, Bcl-2 dephosphorylation, caspase-2 activation, and apoptosis.
Topics: Animals; Apoptosis; Caspase 2; Caspases; Cells, Cultured; Ceramides; Enzyme Activation; Etoposide; Lithium; Methylation; Mice; Phosphoprotein Phosphatases; Phosphorylation; Protein Phosphatase 2; Protein Subunits; Proto-Oncogene Proteins c-bcl-2 | 2006 |